$40.03
1.152.96%
Last update: Nov 2, 11:01 AM
Phibro Animal Health Corp
PAHCNASDAQ
Phibro Animal Health (PAHC) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
Phibro Animal Health (PAHC) last issued guidance on August 26, 2026 for fiscal year 2027. The company guided earnings per share in the range of $3.41 - $3.59, compared to a consensus EPS estimate of $3.34. Phibro Animal Health also guided revenue in the range of $1.55B - $1.6B for the period.
Compared to prior guidance, Phibro Animal Health raised its revenue forecast from a prior range of $1.46B - $1.5B.
Phibro Animal Health has issued 16 guidance updates between November 9, 2022 and August 26, 2026. During this period, the company raised its outlook 9 times and lowered it 1 time, providing investors with insight into management's evolving expectations.
| Metric | Q4 '26 | Q3 '26 | Q2 '26 | Q1 '26 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $0.72 | $0.71 | $0.68 | $0.60 |
| Actual | $0.85 | $0.76 | $0.87 | $0.73 |
| Surprise | +18.1% | +7.04% | +27.9% | +21.7% |
| Revenue | ||||
| Estimate | $375.9M | $365.8M | $356.2M | $349.1M |
| Actual | $396.7M | $383.5M | $373.9M | $363.9M |
| Surprise | +5.53% | +4.85% | +4.97% | +4.23% |
| Metric | Q1 '27E | Q2 '27E | Q3 '27E | Q4 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $0.78 | $0.94 | $0.86 | $0.89 |
| Revenue | ||||
| Consensus | $382.2M | $392.3M | — | — |
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q4 | Aug 26, 2026 | $0.85 | $0.72 | 18.1 % |
| Q3 | May 6, 2026 | $0.76 | $0.71 | 7.04 % |
| Q2 | Feb 4, 2026 | $0.87 | $0.68 | 27.9 % |
| Q1 | Nov 5, 2025 | $0.73 | $0.60 | 21.7 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q4 | Aug 26, 2026 | $396.70M | $375.90M | 5.53 % |
| Q3 | May 6, 2026 | $383.54M | $365.80M | 4.85 % |
| Q2 | Feb 4, 2026 | $373.90M | $356.20M | 4.97 % |
| Q1 | Nov 5, 2025 | $363.90M | $349.13M | 4.23 % |
